Literature DB >> 5724974

Metabolism of beta-methylaspartate by a pseudomonad.

O K Sebek, H A Barker.   

Abstract

A bacterium was isolated from soil which utilizes threo-beta-methyl-l-aspartate, certain other amino acids, and a variety of organic substances as single energy sources. It is, or closely resembles, Pseudomonas putida biotype B. The ability of this organism to rapidly decompose such amino acids is dependent on inducible enzyme systems. Dialyzed cell-free extracts of this bacterium metabolize beta-methylaspartate only when catalytic amounts of alpha-ketoglutarate, or pyruvate, and pyridoxal phosphate are also present. The main products formed from beta-methylaspartate under these conditions are alpha-aminobutyrate, carbon dioxide, and alpha-ketobutyrate. When l-aspartate is substituted for beta-methylaspartate in this system, it is converted mainly to alanine and carbon dioxide. beta-Methyloxalacetate is decarboxylated, and the resulting alpha-ketobutyrate is converted enzymatically in the presence of glutamate to alpha-aminobutyrate which accumulates. The added keto acids are converted, in part, to the corresponding amino acids probably by transamination. The data indicate that beta-methylaspartate is converted to alpha-aminobutyrate, and aspartate to alanine, by a circuitous transamination-beta-decarboxylation-transamination sequence rather than by a direct beta-decarboxylation.

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5724974      PMCID: PMC252562          DOI: 10.1128/jb.96.6.2094-2098.1968

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  11 in total

1.  CONTROL OF ASPARTATE BETA-DECARBOXYLASE ACTIVITY BY TRANSAMINATION.

Authors:  A NOVOGRODSKY; A MEISTER
Journal:  J Biol Chem       Date:  1964-03       Impact factor: 5.157

2.  THE GLUTAMATE MUTASE SYSTEM. ASSAYS AND PROPERTIES.

Authors:  H A BARKER; V ROOZE; F SUZUKI; A A IODICE
Journal:  J Biol Chem       Date:  1964-10       Impact factor: 5.157

3.  THE FORMATION OF ISOLEUCINE FROM BETA-METHYLASPARTIC ACID IN ESCHERICHIA COLI W.

Authors:  T ABRAMSKY; D SHEMIN
Journal:  J Biol Chem       Date:  1965-07       Impact factor: 5.157

4.  Structure and function of cobamide coenzymes.

Authors:  H A BARKER
Journal:  Fed Proc       Date:  1961-12

5.  The metabolism of beta-methylaspartic acid in brain and liver.

Authors:  S R MARDASHEW
Journal:  Clin Chim Acta       Date:  1961-03       Impact factor: 3.786

6.  Enzymic preparation and characterization of an alpha-L-beta-methylaspartic acid.

Authors:  H A BARKER; R D SMYTH; E J WAWSZKIEWICZ; M N LEE; R M WILSON
Journal:  Arch Biochem Biophys       Date:  1958-12       Impact factor: 4.013

7.  The purification and properties of beta-methylaspartase.

Authors:  H A BARKER; R D SMYTH; R M WILSON; H WEISSBACH
Journal:  J Biol Chem       Date:  1959-02       Impact factor: 5.157

8.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

Review 9.  Biochemical functions of corrinoid compounds. The sixth Hopkins memorial lecture.

Authors:  H A Barker
Journal:  Biochem J       Date:  1967-10       Impact factor: 3.857

10.  The aerobic pseudomonads: a taxonomic study.

Authors:  R Y Stanier; N J Palleroni; M Doudoroff
Journal:  J Gen Microbiol       Date:  1966-05
View more
  3 in total

Review 1.  Nonproteinogenic amino acid building blocks for nonribosomal peptide and hybrid polyketide scaffolds.

Authors:  Christopher T Walsh; Robert V O'Brien; Chaitan Khosla
Journal:  Angew Chem Int Ed Engl       Date:  2013-05-31       Impact factor: 15.336

2.  Mechanism of biosynthesis of 2-oxo-3-methylvalerate in Chlorobium vibrioforme.

Authors:  T Nesbakken; P Kolsaker; J Ormerod
Journal:  J Bacteriol       Date:  1988-07       Impact factor: 3.490

3.  Alternate pathway for isoleucine biosynthesis in Escherichia coli.

Authors:  A T Phillips; J I Nuss; J Moosic; C Foshay
Journal:  J Bacteriol       Date:  1972-02       Impact factor: 3.490

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.